» Articles » PMID: 32354380

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

Overview
Date 2020 May 2
PMID 32354380
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Elevated triglyceride-rich lipoprotein (TRL) and small-dense low-density lipoprotein (sdLDL) particles are hallmarks of atherogenic dyslipidemia, and their cholesterol content is hypothesized to drive atherosclerotic risk. Prospective epidemiological data pertaining to cholesterol content of TRLs and sdLDL in primary prevention populations are mostly limited to coronary heart disease.

Objectives: The purpose of this study was to prospectively evaluate whether triglyceride-rich lipoprotein cholesterol (TRL-C) and small-dense low-density lipoprotein cholesterol (sdLDL-C) concentrations associate with composite and individual incident cardiovascular disease (CVD) outcomes including myocardial infarction (MI), ischemic stroke (IS), and peripheral artery disease (PAD).

Methods: In a prospective case-cohort study within the Women's Health Study, TRL-C and sdLDL-C (mg/dl) were directly measured in baseline blood specimens of case subjects (n = 480) and the reference subcohort (n = 496). Risk associations were evaluated for total CVD (MI, IS, PAD, and CVD death), coronary and cerebrovascular disease (MI, IS, CVD death), and individual outcomes (MI, IS, and PAD). Models were adjusted for traditional risk factors, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein.

Results: The risk of both composite outcomes significantly increased across quartiles of TRL-C and sdLDL-C. TRL-C was significantly associated with MI and PAD (MI hazard ratio [HR]: 3.05 [95% confidence interval (CI): 1.46 to 6.39]; p = 0.002; PAD HR: 2.58 [95% CI: 1.18 to 5.63]; p = 0.019), whereas sdLDL-C was significantly associated with MI alone (HR: 3.71 [95% CI: 1.59 to 8.63]; p < 0.001). Both markers weakly associated with IS. Association patterns were similar for continuous exposures and, for TRL-C, among subjects with low atherogenic particle concentrations (apolipoprotein B <100 mg/dl).

Conclusions: TRL-C strongly associates with future MI and PAD events, whereas sdLDL-C strongly associates with MI alone. These findings signal that the cholesterol content of TRLs and sdLDL influence atherogenesis independently of low-density lipoprotein cholesterol, and high sensitivity C-reactive protein, with potentially different potency across vascular beds. (Women's Health Study; NCT00000479).

Citing Articles

Estimated sdLDL-C as a biomarker of hepatic steatosis severity in MASLD: a retrospective study.

Jiang S, Zhang F, Yang H, Han X, Mao J, Zheng G BMC Gastroenterol. 2025; 25(1):168.

PMID: 40082781 PMC: 11907928. DOI: 10.1186/s12876-025-03759-5.


Correlation of sdLDL-C and Apob with the degree of cerebral artery stenosis in posterior circulation stroke.

Sun Z, Liu J, Wang A, Si Z Sci Rep. 2025; 15(1):8343.

PMID: 40069330 PMC: 11897327. DOI: 10.1038/s41598-025-93074-6.


Association of estimated small dense low-density lipoprotein cholesterol with diabetes mellitus: a large-scale multicenter retrospective cohort study.

Gao Y BMC Endocr Disord. 2025; 25(1):66.

PMID: 40065380 PMC: 11895197. DOI: 10.1186/s12902-025-01880-w.


Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study.

Mo D, Zhang P, Zhang M, Dai H, Guan J Cardiovasc Diabetol. 2025; 24(1):116.

PMID: 40065297 PMC: 11895360. DOI: 10.1186/s12933-025-02675-y.


Association of the atherogenic index of plasma with frailty in U.S. adults: a cross-sectional study based on NHANES.

Yan S, Chai K, Yang J, Wang H Lipids Health Dis. 2025; 24(1):84.

PMID: 40050964 PMC: 11884020. DOI: 10.1186/s12944-025-02504-x.


References
1.
Matsuo Y, Takumi T, Mathew V, Chung W, Barsness G, Rihal C . Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis. 2012; 223(2):365-71. PMC: 3427929. DOI: 10.1016/j.atherosclerosis.2012.05.023. View

2.
Mahley R, Innerarity T, Rall Jr S, Weisgraber K . Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia. Ann N Y Acad Sci. 1985; 454:209-21. DOI: 10.1111/j.1749-6632.1985.tb11860.x. View

3.
Varbo A, Freiberg J, Nordestgaard B . Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study. Clin Chem. 2017; 64(1):219-230. DOI: 10.1373/clinchem.2017.279463. View

4.
Shaikh M, Wootton R, Nordestgaard B, Baskerville P, LUMLEY J, La Ville A . Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb. 1991; 11(3):569-77. DOI: 10.1161/01.atv.11.3.569. View

5.
Nordestgaard B . Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. Circ Res. 2016; 118(4):547-63. DOI: 10.1161/CIRCRESAHA.115.306249. View